Improving hyperglycemic effect of FGF-21 is associated with alleviating inflammatory state in diabetes

Nan Wang1, Tong-Yu Xu2, Xu Zhang1

  • 1Biopharmaceutical Lab, Life Science college, Northeast Agricultural University, Harbin 150030, China.

Insights

Fibroblast growth factor 21 (FGF-21) effectively lowers blood sugar and reduces inflammation in Type 2 diabetes models. FGF-21 improves glucose metabolism and combats inflammatory responses linked to insulin resistance.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Immunology

Background:

  • Type 2 diabetes mellitus (T2DM) is characterized by impaired glucose metabolism and chronic inflammation.
  • Fibroblast growth factor 21 (FGF-21) is a key metabolic regulator with potential anti-inflammatory properties.
  • The specific impact of FGF-21 on the inflammatory state in diabetes remains largely uninvestigated.

Purpose of the Study:

  • To investigate the effects of FGF-21 on hyperglycemia and inflammation in a Type 2 diabetes mouse model.
  • To determine if FGF-21 can ameliorate insulin resistance and improve glucose metabolism in vitro.

Main Methods:

  • Utilized db/db mice as a model for Type 2 diabetes.
  • Administered FGF-21 to assess its impact on serum and white adipose tissue inflammatory markers.
  • Induced insulin resistance in 3T3-L1 adipocytes using TNF-α for in vitro analysis.
  • Examined the effect of FGF-21 on glucose metabolism and inflammatory gene expression in adipocytes.
  • Investigated the role of the NF-κB signaling pathway in FGF-21's mechanism of action.

Main Results:

  • FGF-21 demonstrated a potent and sustained hypoglycemic effect in db/db mice.
  • Significant reduction in inflammatory markers was observed in both serum and white adipose tissue following FGF-21 treatment.
  • In vitro, FGF-21 repressed the gene expression of inflammatory factors induced by TNF-α, thereby improving glucose metabolism in insulin-resistant adipocytes.
  • FGF-21 enhanced glucose uptake in TNF-α-induced insulin-resistant adipocytes by inhibiting the NF-κB signaling pathway.

Conclusions:

  • FGF-21 exhibits significant hypoglycemic and anti-inflammatory effects in the context of Type 2 diabetes.
  • FGF-21 improves glucose metabolism and insulin resistance, partly through the inhibition of the NF-κB signaling pathway.
  • These findings highlight FGF-21 as a potential therapeutic agent for managing both hyperglycemia and inflammation in Type 2 diabetes.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
17.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
8.1K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
511
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.9K